Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Too Few Americans Getting Screened for Cancer: CDC

Posted 26 Jul 2018 by

THURSDAY, July 26, 2018 – Routine checks for breast, prostate, cervical and colon cancer save lives, but screening rates for all but colon cancer have stalled in recent years, U.S. health officials report. According to the new U.S. Centers for Disease Control and Prevention study, the number of Americans getting recommended cancer screening remains below target levels. This is especially the ...

Large U.S. Study Targets Prostate Cancer in Black Men

Posted 23 Jul 2018 by

MONDAY, July 23, 2018 – Black men in the United States have higher rates of aggressive prostate cancer than other males. Now, a $26.5 million study is underway to figure out why. The U.S. National Institutes of Health and the Prostate Cancer Foundation have launched the study to investigate social, environmental and genetic factors behind this disparity. "No group in the world is hit harder by ...

Could an Early Supper Lower Breast, Prostate Cancer Risk?

Posted 18 Jul 2018 by

WEDNESDAY, July 18, 2018 – Having a late dinner and heading straight to bed may boost your risk of breast or prostate cancer, a new study suggests. Spanish researchers analyzed data from 621 prostate cancer patients and 1,205 breast cancer patients, as well as 872 men and 1,321 women without these cancers. People who ate their evening meal before 9 p.m. or waited at least two hours after supper ...

FDA Approves Xtandi (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

Posted 16 Jul 2018 by

TOKYO and NEW YORK, July 13, 2018 /PRNewswire/ – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for Xtandi (enzalutamide), following FDA Priority Review designation, based on results from the Phase 3 PROSPER trial. The ...

Could Targeted Drug Enzalutamide Help Keep Aggressive Prostate Cancer in Check?

Posted 27 Jun 2018 by

WEDNESDAY, June 27, 2018 – Men with localized high-risk prostate cancer can slow its spread by using a cancer drug that's already on the market, a new clinical trial shows. The targeted drug enzalutamide (Xtandi) reduced by 71 percent these men's risk of either dying from their prostate cancer or having the cancer spread to other organs, compared against a placebo. The drug also delayed their ...

New DNA Test May Predict Prostate Cancer Risk

Posted 11 Jun 2018 by

MONDAY, June 11, 2018 – A new genetic test can identify men most likely to develop prostate cancer, a new report contends. According to the new study, the scientists identified 63 new genetic variants associated with increased risk of prostate cancer, and combined them with more than 100 previously identified variants to create the new test. The test identifies the 1 percent of men who are at ...

Blacks With Prostate Cancer May Fare Better Than Whites

Posted 1 Jun 2018 by

FRIDAY, June 1, 2018 – Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests. Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for black men was initially the same as for white men – an average of 21 months. But after taking into account other factors – such as site of the cancer ...

Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer

Posted 24 May 2018 by

MUMBAI & PRINCETON, N.J. & KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that one of Sun Pharma’s wholly owned subsidiary companies has received approval from the U.S. Food and Drug Administration (FDA) for Yonsa (abiraterone acetate), ...

U.S. Cancer Death Rate Declines Again, But Prostate Cancer Incidence Rises

Posted 22 May 2018 by

TUESDAY, May 22, 2018 – There's good news for Americans in the war against cancer. Cancer deaths continue to decline nationwide, according to the Annual Report to the Nation on the Status of Cancer. But the report also points to one troubling trend – prostate cancer deaths are creeping up again after years of decline, suggesting that controversy over the best way to screen for the disease may ...

Expert Panel Highlights Patient Choice for Prostate Cancer Screen

Posted 8 May 2018 by

TUESDAY, May 8, 2018 – More men could receive PSA blood tests for prostate cancer under revised guidelines released Tuesday by the nation's leading panel on preventive medicine. The U.S. Preventive Services Task Force (USPSTF) now recommends that men aged 55 to 69 decide for themselves whether to undergo a prostate-specific antigen (PSA) test, after talking it over with their doctor. This blood ...

Could a Tattoo Someday Spot Your Cancer?

Posted 19 Apr 2018 by

THURSDAY, April 19, 2018 – Tattoos serve many purposes, perhaps expressing artistry, loyalty or love. Now, scientists working with mice say they've engineered a medical "tattoo" that can screen for early signs of major disease. The biomedical tattoo is made up of cells embedded with sensors that measure levels of blood calcium. It's initially invisible when implanted under the skin. But the ...

Diet, Exercise Can Ease Side Effects of Prostate Cancer Treatment

Posted 9 Apr 2018 by

MONDAY, April 9, 2018 – Exercise and healthy eating can counter the harmful side effects of hormone therapy for prostate cancer, a new study suggests. Androgen-deprivation therapy suppresses testosterone and other male hormones that drive prostate cancer growth. But suppressing those hormones leads to loss of muscle mass and strength as well as increased body fat, which puts patients at risk for ...

A Light Breakfast Might Cut Cost of Pricey Prostate Cancer Drug Zytiga

Posted 28 Mar 2018 by

WEDNESDAY, March 28, 2018 – Here's one way to cut the cost of a $10,000-a-month prostate cancer drug: Take it with food, some researchers suggest. Investigators said they found that taking Zytiga (abiraterone acetate) with a low-fat breakfast boosts its efficiency. That could make it more convenient and significantly cheaper, the new study suggested. Zytiga is the standard medicine for prostate ...

His Prostate Cancer Becomes Her Struggle, Too

Posted 24 Mar 2018 by

FRIDAY, March 23, 2018 – Difficulties tied to prostate cancer may not be limited to men. Many wives of men with advanced prostate cancer say their husband's illness has harmed their own health, a new study finds. "Many prostate cancer patients have a hard time, both physically and emotionally. This work shows that this stress can spill over and affect wives and partners," said Hein Van Poppel, a ...

Dad Can Pass on Ovarian Cancer Genes, Too

Posted 16 Feb 2018 by

FRIDAY, Feb. 16, 2018 – A gene mutation that's passed down from a father is associated with earlier onset of ovarian cancer in daughters and prostate cancer in the father and his sons, a new study suggests. Previous research had shown that sisters of women with ovarian cancer have a higher risk for the disease than their mother, but the reasons for this were unclear. "Our study may explain why ...

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups


Related Drug Support Groups

estradiol, Premarin, Estrace, ethinyl estradiol, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, Eligard, view more... Casodex, Taxotere, capecitabine, Xtandi, Cenestin, bicalutamide, cyclophosphamide, flax, esterified estrogens, Menest, degarelix, Enjuvia, Firmagon, leuprolide, goserelin, Xofigo, Progynova, conjugated estrogens, Trelstar, Provenge, flutamide, Erleada, Trelstar LA, Flax Seed Oil, Supprelin LA, Sandrena, Premarin Intravenous, Yonsa, Vantas, abiraterone, radium 223 dichloride, triptorelin, Thaissept, Stilphostrol, cabazitaxel, sipuleucel-t, Estratab, nilutamide, Systen, mitoxantrone, Jevtana, histrelin, Docefrez, estramustine, docetaxel, Zoladex 3-Month, diethylstilbestrol, Thais, Provames, aminoglutethimide, Plenaxis, Novantrone, Nilandron, Trelstar Depot, Emcyt, Viadur, Delestrogen, Cytadren, Estinyl, Oromone, Eulexin, Valergen, apalutamide, Progynova TS, Zumenon, enzalutamide, Primogyn Depot, abarelix